GABRA4
Basic information
Region (hg38): 4:46918899-46993581
Links
Phenotypes
GenCC
Source:
- developmental and epileptic encephalopathy (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (12 variants)
- not provided (7 variants)
- GABRA4-related Epileptic and Neurodevelopmental Disorder (1 variants)
- not specified (1 variants)
- GABRA4-related developmental and epileptic encephalopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GABRA4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 12 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 1 | ||||
non coding ? | 1 | |||||
Total | 0 | 0 | 12 | 5 | 4 |
Variants in GABRA4
This is a list of pathogenic ClinVar variants found in the GABRA4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-46928234-A-T | not specified | Uncertain significance (Dec 30, 2023) | ||
4-46928264-T-C | Likely benign (Aug 08, 2018) | |||
4-46928373-G-A | not specified | Uncertain significance (Nov 14, 2023) | ||
4-46928416-T-C | not specified | Uncertain significance (Mar 08, 2024) | ||
4-46928459-G-A | Benign (Apr 06, 2018) | |||
4-46928463-C-T | not specified | Likely benign (Jun 06, 2023) | ||
4-46928488-C-G | not specified | Uncertain significance (Sep 22, 2022) | ||
4-46928613-C-T | not specified | Likely benign (May 06, 2022) | ||
4-46928665-G-C | not specified | Uncertain significance (Sep 25, 2023) | ||
4-46928693-A-C | not specified | Uncertain significance (Sep 14, 2022) | ||
4-46928706-T-C | not specified | Uncertain significance (Jan 23, 2023) | ||
4-46964994-C-G | not specified | Uncertain significance (Feb 27, 2024) | ||
4-46965017-G-A | GABRA4-related Epileptic and Neurodevelopmental Disorder | Uncertain significance (Aug 31, 2022) | ||
4-46965041-T-C | GABRA4-related disorder | Likely benign (Jun 02, 2023) | ||
4-46965099-G-A | Benign (Jul 20, 2018) | |||
4-46965129-G-C | Likely benign (Mar 29, 2018) | |||
4-46965205-G-A | Uncertain significance (Jan 24, 2024) | |||
4-46965205-G-T | GABRA4-related developmental and epileptic encephalopathy | Uncertain significance (Mar 31, 2022) | ||
4-46971098-C-A | not specified | Uncertain significance (Mar 24, 2023) | ||
4-46974235-T-A | not specified | Uncertain significance (Sep 17, 2021) | ||
4-46974259-A-C | not specified | Uncertain significance (Oct 12, 2022) | ||
4-46974262-C-G | not specified | Uncertain significance (Jan 27, 2022) | ||
4-46974334-C-A | not specified | Uncertain significance (Oct 06, 2021) | ||
4-46977528-T-G | not specified | Uncertain significance (Jul 30, 2023) | ||
4-46977529-C-T | Likely benign (Apr 02, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GABRA4 | protein_coding | protein_coding | ENST00000264318 | 9 | 75508 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.779 | 0.221 | 125732 | 0 | 14 | 125746 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.00 | 208 | 307 | 0.678 | 0.0000156 | 3608 |
Missense in Polyphen | 62 | 156.91 | 0.39513 | 1901 | ||
Synonymous | -1.64 | 134 | 112 | 1.20 | 0.00000607 | 1108 |
Loss of Function | 3.62 | 4 | 22.6 | 0.177 | 0.00000119 | 293 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000623 | 0.0000615 |
Ashkenazi Jewish | 0.000113 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000133 | 0.0000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000383 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.;
- Pathway
- Retrograde endocannabinoid signaling - Homo sapiens (human);GABAergic synapse - Homo sapiens (human);Nicotine addiction - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Taste transduction - Homo sapiens (human);Morphine addiction - Homo sapiens (human);GABA receptor Signaling;cardiac protection against ros;gamma-aminobutyric acid receptor life cycle pathway;GABA A receptor activation;Neuronal System;GABA receptor activation;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.0240
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.26
Haploinsufficiency Scores
- pHI
- 0.155
- hipred
- Y
- hipred_score
- 0.774
- ghis
- 0.472
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.881
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gabra4
- Phenotype
- normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- signal transduction;gamma-aminobutyric acid signaling pathway;chemical synaptic transmission;central nervous system development;ion transmembrane transport;regulation of membrane potential;nervous system process;synaptic transmission, GABAergic;regulation of postsynaptic membrane potential;chloride transmembrane transport;regulation of response to drug
- Cellular component
- plasma membrane;integral component of plasma membrane;cell junction;dendrite membrane;chloride channel complex;neuron projection;synapse;postsynapse;GABA-ergic synapse;integral component of postsynaptic specialization membrane;GABA-A receptor complex
- Molecular function
- GABA-A receptor activity;extracellular ligand-gated ion channel activity;inhibitory extracellular ligand-gated ion channel activity;chloride channel activity;benzodiazepine receptor activity;GABA-gated chloride ion channel activity;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential